Heron Therapeutics, INC. /De/ (HRTX) — SC 13D/A Filings
All SC 13D/A filings from Heron Therapeutics, INC. /De/. Browse 1 SC 13D/A reports with AI-powered summaries and risk analysis.
SC 13D/A Filings (1)
-
Rubric Capital Boosts Heron Therapeutics Stake to 10.4%
— May 31, 2024 Risk: medium
Rubric Capital Management LP, on May 31, 2024, filed an amendment to its Schedule 13D, disclosing a beneficial ownership of 10.4% of Heron Therapeutics, Inc. co
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX